FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783251885> ?p ?o ?g. }

• W2783251885 endingPage "206" @default.
• W2783251885 startingPage "197" @default.
• W2783251885 abstract "Anaplastic thyroid cancer (ATC) constitutes less than 2% of total thyroid cancers but accounts for 20–40% of thyroid cancer-related deaths. Cancer stem cell drug resistance represents a primary factor hindering treatment. This study aimed to develop targeted agents against thyroid malignancy, focusing on individual and synergistic effects of HNHA (histone deacetylase), lenvatinib (FGFR), and sorafenib (tyrosine kinase) inhibitors. Patients with biochemically and histologically proven papillary thyroid cancer (PTC) and ATC were included. Cell samples were obtained from patients at the Thyroid Cancer Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. PTC and ATC cells were treated with lenvatinib or sorafenib, alone or in combination with HNHA. Tumor-bearing mice (10/group) were administered 10 mg/kg lenvatinib (p.o.) or 40 mg/kg sorafenib (p.o.), alone or in combination with 25 mg/kg HNHA (i.p.) once every three days. Gene expression in patient-derived PTC and ATC cells was compared using a microarray approach. Cellular apoptosis and proliferation were examined by immunohistochemistry and MTT assays. Tumor volume and cell properties were examined in the mouse xenograft model. HNHA-lenvatinib combined treatment induced markers of cell cycle arrest and apoptosis and suppressed anti-apoptosis markers, epithelial-mesenchymal transition (EMT), and the FGFR signaling pathway. Combined treatment induced significant tumor shrinkage in the xenograft model. HNHA-lenvatinib combination treatment thus blocked the FGFR signaling pathway, which is important for EMT. Treatment with HNHA-lenvatinib combination was more effective than either agent alone or sorafenib-HNHA combination. These findings have implications for ATC treatment by preventing drug resistance in cancer stem cells." @default.
• W2783251885 created "2018-01-26" @default.
• W2783251885 creator A5026256793 @default.
• W2783251885 creator A5028632892 @default.
• W2783251885 creator A5039252737 @default.
• W2783251885 creator A5048899772 @default.
• W2783251885 creator A5050302535 @default.
• W2783251885 creator A5054188737 @default.
• W2783251885 creator A5083183967 @default.
• W2783251885 creator A5090931143 @default.
• W2783251885 date "2018-02-01" @default.
• W2783251885 modified "2023-10-15" @default.
• W2783251885 title "Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells" @default.
• W2783251885 cites W1804495077 @default.
• W2783251885 cites W1967792499 @default.
• W2783251885 cites W1968134619 @default.
• W2783251885 cites W1983712256 @default.
• W2783251885 cites W2002889122 @default.
• W2783251885 cites W2010521682 @default.
• W2783251885 cites W2010868474 @default.
• W2783251885 cites W2014047844 @default.
• W2783251885 cites W2014445008 @default.
• W2783251885 cites W2014691022 @default.
• W2783251885 cites W2015169823 @default.
• W2783251885 cites W2026814171 @default.
• W2783251885 cites W2028593825 @default.
• W2783251885 cites W2036844438 @default.
• W2783251885 cites W2049086297 @default.
• W2783251885 cites W2058908426 @default.
• W2783251885 cites W2069792474 @default.
• W2783251885 cites W2094109552 @default.
• W2783251885 cites W2103771206 @default.
• W2783251885 cites W2113395685 @default.
• W2783251885 cites W2131487381 @default.
• W2783251885 cites W2133735831 @default.
• W2783251885 cites W2134581357 @default.
• W2783251885 cites W2140765540 @default.
• W2783251885 cites W2145150141 @default.
• W2783251885 cites W2168076926 @default.
• W2783251885 cites W2183602213 @default.
• W2783251885 cites W2185435318 @default.
• W2783251885 cites W2290709758 @default.
• W2783251885 cites W2404869932 @default.
• W2783251885 cites W2472922625 @default.
• W2783251885 cites W2521580851 @default.
• W2783251885 cites W2539097622 @default.
• W2783251885 cites W2546654144 @default.
• W2783251885 cites W2559788800 @default.
• W2783251885 cites W2587978856 @default.
• W2783251885 cites W2598230851 @default.
• W2783251885 cites W2606001457 @default.
• W2783251885 cites W784935995 @default.
• W2783251885 cites W95463455 @default.
• W2783251885 cites W1979370076 @default.
• W2783251885 doi "https://doi.org/10.1016/j.neo.2017.12.003" @default.
• W2783251885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5767911" @default.
• W2783251885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29331886" @default.
• W2783251885 hasPublicationYear "2018" @default.
• W2783251885 type Work @default.
• W2783251885 sameAs 2783251885 @default.
• W2783251885 citedByCount "32" @default.
• W2783251885 countsByYear W27832518852018 @default.
• W2783251885 countsByYear W27832518852019 @default.
• W2783251885 countsByYear W27832518852020 @default.
• W2783251885 countsByYear W27832518852021 @default.
• W2783251885 countsByYear W27832518852022 @default.
• W2783251885 countsByYear W27832518852023 @default.
• W2783251885 crossrefType "journal-article" @default.
• W2783251885 hasAuthorship W2783251885A5026256793 @default.
• W2783251885 hasAuthorship W2783251885A5028632892 @default.
• W2783251885 hasAuthorship W2783251885A5039252737 @default.
• W2783251885 hasAuthorship W2783251885A5048899772 @default.
• W2783251885 hasAuthorship W2783251885A5050302535 @default.
• W2783251885 hasAuthorship W2783251885A5054188737 @default.
• W2783251885 hasAuthorship W2783251885A5083183967 @default.
• W2783251885 hasAuthorship W2783251885A5090931143 @default.
• W2783251885 hasBestOaLocation W27832518851 @default.
• W2783251885 hasConcept C121608353 @default.
• W2783251885 hasConcept C126322002 @default.
• W2783251885 hasConcept C143998085 @default.
• W2783251885 hasConcept C2776264508 @default.
• W2783251885 hasConcept C2778019345 @default.
• W2783251885 hasConcept C2778695046 @default.
• W2783251885 hasConcept C2779013556 @default.
• W2783251885 hasConcept C2779761222 @default.
• W2783251885 hasConcept C2780256643 @default.
• W2783251885 hasConcept C2781461381 @default.
• W2783251885 hasConcept C502942594 @default.
• W2783251885 hasConcept C55427017 @default.
• W2783251885 hasConcept C71924100 @default.
• W2783251885 hasConcept C76419328 @default.
• W2783251885 hasConcept C96232424 @default.
• W2783251885 hasConceptScore W2783251885C121608353 @default.
• W2783251885 hasConceptScore W2783251885C126322002 @default.
• W2783251885 hasConceptScore W2783251885C143998085 @default.
• W2783251885 hasConceptScore W2783251885C2776264508 @default.
• W2783251885 hasConceptScore W2783251885C2778019345 @default.
• W2783251885 hasConceptScore W2783251885C2778695046 @default.

• next